IQV — IQVIA HOLDINGS INC.
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1478242 ·
Last close
$257.60
Market Cap
$42.45B
52W High
$284.50
52W Low
$154.50
ADV30
1,392,626
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 4,368,000,000 | 1,435,000,000 | 569,000,000 | 256,000,000 | 29,881,000,000 | 1,909,000,000 | 23,580,000,000 |
| Mar 2026 | 4,151,000,000 | 1,355,000,000 | 565,000,000 | 274,000,000 | 29,675,000,000 | 1,947,000,000 | 23,326,000,000 |
| Dec 2025 | 4,364,000,000 | 1,436,000,000 | 651,000,000 | 514,000,000 | 29,944,000,000 | — | 23,314,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,736,000,000
Investing CF
$-2,240,000,000
Financing CF
$-34,000,000
CapEx
$-657,000,000
Dividends Paid
—
Buybacks
$-1,162,000,000
EPS Diluted TTM
$8.23
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$8,305,000,000
Inventory
—
Receivables
$3,332,000,000
ST Investments
$173,000,000
EBIT TTM
$2,337,000,000
Pretax Income TTM
$1,552,000,000
Interest Exp TTM
$785,000,000
Analysts
17
Yahoo Snapshot (yfinance, live)
Total Revenue
$17,311,000,576
EBITDA
$3,118,000,128
Free Cash Flow
$2,115,874,944
Enterprise Value
$58,078,982,144
Total Cash
$2,422,000,128
Total Debt
$16,314,000,384
Shares Out
164,800,000
Trailing EPS
$8.22
Book Value
$40.41
ROE
21.4%
ROA
5.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,310,000,000 | 2,287,000,000 | 1,360,000,000 | 29,944,000,000 | 23,314,000,000 | 6,503,000,000 | 2,654,000,000 |
| Dec 2024 | 15,405,000,000 | 2,269,000,000 | 1,373,000,000 | 26,899,000,000 | 20,832,000,000 | 6,067,000,000 | 2,716,000,000 |
| Dec 2023 | 14,984,000,000 | 2,061,000,000 | 1,358,000,000 | 26,681,000,000 | 20,569,000,000 | 6,112,000,000 | 2,149,000,000 |
| Dec 2022 | 14,410,000,000 | 1,827,000,000 | 1,091,000,000 | 25,337,000,000 | 19,572,000,000 | 5,765,000,000 | 2,260,000,000 |
TTM Snapshot
Revenues TTM
$16,983,000,000
NetIncome TTM
$1,375,000,000
OpCashFlow TTM
—
Assets (Latest)
$29,881,000,000
Forward EPS
$14.22
Max Pain — expiry 2027-01-15
max pain strike: $240.00 · spot: $257.84 · call oi: 2,123 · put oi: 1,520
Expected Move to 2027-01-15:
±$32.90
(12.76%) —
implied range
$224.94 –
$290.74
· ATM straddle on $260.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $54.38B | $690.24 | — |
| INCY | INCYTE CORP | $24.27B | $119.09 | — |
| MEDP | Medpace Holdings, Inc. | $18.27B | $653.09 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $15.92B | $332.16 | — |
| ICLR | ICON PLC | $15.05B | $195.02 | — |
News headlines (Yahoo Finance, 1h cache)
What iShares A.I. Innovation ETF (BAI) Bought: CoreWeave Leads on Nov. 16
2026-11-18 11:04 · Yahoo
ETFs Are Net Sellers of IQVIA (IQV) on Nov. 13
2026-11-17 11:03 · Yahoo
IQVIA Stock Jumps 59% in 6 Months: Here's What You Should Know
2026-11-13 14:12 · Yahoo
iShares A.I. Innovation (BAI) Buys $11.9 Million More IQVIA on Nov. 11
2026-11-13 11:04 · Yahoo
IQVIA: 3 Key Takeaways for Long-Term Investors
2026-11-10 01:52 · Yahoo
IQV Q3 deep dive: AI adoption and clinical momentum drive growth, guidance raised
2026-10-30 21:31 · Yahoo
5 revealing analyst questions from IQVIA’s Q3 earnings call
2026-10-30 21:15 · Yahoo
IQVIA (IQV) Q3 Earnings Beat Meets Valuation And Debt Questions
2026-10-28 08:09 · Yahoo
What IQVIA (IQV) Said on Its Q3 Earnings Call
2026-10-27 20:04 · Yahoo
IQVIA (IQV) Q3 2026 Earnings Call Transcript
2026-10-27 18:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.